← Full program

Emerging Technology: Abbott

Part of Advanced Engineering Principles in Neuromodulation: Next-Generation SCS and DBS Technologies

Details

Date
Thursday, January 21, 2027
Time
1:55 PM – 2:10 PM
Session type
Pre-Conference Session
Schedule
See this day

About

This course provides a deep dive into the advanced engineering behind next-generation spinal cord stimulation (SCS) and deep brain stimulation (DBS) technologies. The morning session spotlights academic leaders sharing foundational concepts critical to innovation in neuromodulation, covering topics such as implantable pulse generator design, electrode technology, novel stimulation paradigms, neural sensing, clinical testing strategies, and the integration of artificial intelligence. During the afternoon, you'll gain insider perspectives from engineers at top companies, as they present cutting-edge technologies recently launched or in active development. This unique structure bridges theory and application, empowering attendees with unparalleled insight into both the scientific fundamentals and real-world breakthroughs propelling neuromodulation forward. Each session features a dedicated faculty Q&A, offering direct engagement with experts. The course is tailored for a broad audience: neural engineers, clinicians, industry professionals, and researchers invested in advancing neuromodulation therapies. Attendees will explore the intricate engineering challenges of modern devices, discover emerging solutions and technologies, and understand how academic and industry innovators are shaping the future of patient care. Focused on the most relevant technological advancements and ongoing innovations, this course delivers practical knowledge that can immediately inform clinical decision-making, inspire new research directions, and support technology development in neuromodulation.

Presenters

  • David Page, PhD

    David Page, PhD

    Senior Staff Scientist

    Abbott · plano, Texas

    David is an experienced neural engineer and clinical scientist, with 14 years of experience developing neurotechnologies for various severe disease states. He holds a PhD in Biomedical Engineering from the University of Utah, where he conducted groundbreaking clinical research using the renowned Utah Electrode Array. David has over a decade of industry research experience, including 10 years dedicated to neuromodulation for chronic pain and neurological disorders and experience as an enterpreneur and founder. David has authored many patents and peer-reviewed papers and championed many impactful projects from startup through completion.

    Currently, at Abbott, David provides technical and strategic leadership for new neurotechnology development, ensuring alignment of short-term objectives with a visionary long-term impact. His expertise spans medical device development, clinical trial design, pre-clinical studies, and product development, with a particular focus on innovative techniques in neural engineering and advanced neural-computer interfaces. Prior to his tenure at Abbott, David held progressively responsible roles at Avanos Medical.